The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
Blast at police station in Indian Kashmir kills nine, injures 27
Indonesia landslide kills 11 in Central Java, official says 12 missing
Trump says he will likely sue the BBC for up to $5 billion over edited speech
Several people killed as bus crashes into stop in Stockholm
Drone, missile attack on Kyiv injures 26, damages buildings
